Ju‐Whei Lee

Importance of Low- and Moderate-Grade Adverse Events in Patients' Treatment Experience and Treatment Discontinuation: An Analysis of the E1912 Trial

Nathaniel S. O’Connell, Fengmin Zhao, Ju‐Whei Lee et al. · Journal of Clinical Oncology · 2023 · 43 citations · Full text

CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials

Chezi Ganzel, Ju‐Whei Lee, Hugo F. Fernández et al. · Blood Advances · 2021 · 36 citations · Full text

Neurological Disorder, Mixed-phenotype Acute Leukemia, Clinical Neurology +21

ECOG 1308: A phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx (OP).

Shanthi Marur, Ju‐Whei Lee, Anthony J. Cmelak et al. · Journal of Clinical Oncology · 2012 · 24 citations

Surgical Oncology, Pathology, Tumor Biology +21

Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients

Samilia Obeng‐Gyasi, Noah Graham, Shaji Kumar et al. · Blood Cancer Journal · 2022 · 24 citations · Full text

Tumor Genomic Profiling Practices and Perceptions: A Survey of Physicians Participating in the NCI-MATCH Trial

Alice P. Chen, Keith T. Flaherty, Peter J. O’Dwyer et al. · JCO Precision Oncology · 2020 · 20 citations · Full text